Patents by Inventor Yahong Zou

Yahong Zou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160206608
    Abstract: The present invention relates to the use of ROS kinase inhibitors for treating abnormal cell growth in mammals. In particular, the invention provides methods of treating mammals suffering from cancer mediated by at least one genetically altered ROS. In particular, the invention provides methods of treating mammals suffering from cancer mediated by at least one genetically altered ROS by administration of crizotinib.
    Type: Application
    Filed: July 24, 2012
    Publication date: July 21, 2016
    Applicant: Pfizer Inc.
    Inventors: James Gail Christensen, Yahong Zou
  • Patent number: 7825137
    Abstract: The present invention relates to the use of (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine, a novel c-Met/HGFR inhibitor, for treating abnormal cell growth in mammals. In particular, the invention provides methods of treating mammals suffering from cancer.
    Type: Grant
    Filed: November 23, 2006
    Date of Patent: November 2, 2010
    Assignee: Pfizer Inc.
    Inventors: James Gail Christensen, Yahong Zou
  • Publication number: 20080300273
    Abstract: The present invention relates to the use of (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine, a novel c-Met/HGFR inhibitor, for treating abnormal cell growth in mammals. In particular, the invention provides methods of treating mammals suffering from cancer.
    Type: Application
    Filed: November 23, 2006
    Publication date: December 4, 2008
    Inventors: James Gail Christensen, Yahong Zou